Biography Dr. Yen practices Anesthesiology and Critical Care Medicine at the University of California, San Francisco. He is deeply dedicated to providing excellent patient centered care for his patients and their families in the complex perioperative and critical care realms. He is also passionate about education and teaching the next generation of medical students, residents, and clinical fellows in both clinical and non clinical environments. Clinically, he is particularly interested in the application of ultrasound in the perioperative and critical care settings, as well as mechanical circulatory support devices and their management. Role Faculty Location UCSF at Mission Bay UCSF at Mount Zion UCSF at Parnassus Category Clinical Research Specialties Critical Care Medicine Education 09/2025 - Teaching Scholars Program, University of California, San Francisco06/2022 - Diversity, Equity, and Inclusion Champion Training, University of California, San Francisco06/2019 - Critical Care Medicine, University of California, San Francisco06/2018 - Anesthesiology, Columbia University Medical CenterMD, 05/2014 - Medicine, Medical College of WisconsinBS, 05/2009 - Chemical Biology, University of California, Berkeley Publications Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Hirsch KG, Amorim E, Coppler PJ, Drennan IR, Elliott A, Gordon AJ, Jentzer JC, Johnson NJ, Moskowitz A, Mumma BE, Presciutti AM, Rodriguez AJ, Yen AF, Rittenberger JC Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial. I-SPY COVID Consortium Clinical trial design during and beyond the pandemic: the I-SPY COVID trial I-SPY COVID Consortium Embolic Hypodermic Needle Causing Traumatic Cardiac Tamponade: A Case Report. Yen AF, Homer CM, Mohapatra A, Langnas E, Gomez A, Hendrickson CM Central Venous Catheter in the Internal Mammary Vein. House LM, Yen A, Bokoch MP In vitro recombinants of antibiotic-resistant Chlamydia trachomatis strains have statistically more breakpoints than clinical recombinants for the same sequenced loci and exhibit selection at unexpected loci. Srinivasan T, Bruno WJ, Wan R, Yen A, Duong J, Dean D